Weijian Guo

2.8k total citations · 1 hit paper
72 papers, 1.4k citations indexed

About

Weijian Guo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Weijian Guo has authored 72 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 45 papers in Pulmonary and Respiratory Medicine and 14 papers in Surgery. Recurrent topics in Weijian Guo's work include Gastric Cancer Management and Outcomes (30 papers), Colorectal Cancer Treatments and Studies (28 papers) and Lung Cancer Treatments and Mutations (15 papers). Weijian Guo is often cited by papers focused on Gastric Cancer Management and Outcomes (30 papers), Colorectal Cancer Treatments and Studies (28 papers) and Lung Cancer Treatments and Mutations (15 papers). Weijian Guo collaborates with scholars based in China, United States and Germany. Weijian Guo's co-authors include Shukui Qin, Yuxian Bai, Jianming Xu, Jianping Xiong, Zhehai Wang, Liwei Wang, Dongmei Ji, Nong Xu, Guoping Sun and Leizhen Zheng and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Weijian Guo

70 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer: Results From a Randomized, Placebo-Controlled, Parallel-Arm, Phase II Trial

2013 417 citations Shukui Qin, Jianming Xu et al. profile →

Peers

Countries citing papers authored by Weijian Guo

Since Specialization

Citations

This map shows the geographic impact of Weijian Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijian Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijian Guo more than expected).

Fields of papers citing papers by Weijian Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weijian Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijian Guo. The network helps show where Weijian Guo may publish in the future.

Co-authorship network of co-authors of Weijian Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Weijian Guo. A scholar is included among the top collaborators of Weijian Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weijian Guo. Weijian Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chemical Evolution of Bulges of Active Galactic Nuclei in the Early Universe: Roles of Accreting Stars 2026 ·The Astrophysical Journal ·(unknown), (unknown), Yanrong Li, Weijian Guo, (unknown)	0
2	Identifying interface evolutions for achieving stable solid-state Li metal batteries 2025 ·Journal of Energy Chemistry ·Peng Chen, (unknown), Weijian Guo, Bing Ding, Hui Dou, (unknown)	2
3	Granzyme B PET/CT Imaging Evaluates Early Response to Immunotherapy in Gastric Cancer 2024 ·Journal of Nuclear Medicine ·Qiufang Liu, Xiaoping Xu, Ziyi Yang, Jianping Zhang, Jindian Li, Ying Qiao, Silong Hu, Xiaosheng Liu, Weijian Guo, Shaoli Song	4
4	1524P First-line TST001 plus capecitabine and oxaliplatin (CAPOX) for advanced G/GEJ cancer with CLDN18.2 positive overall survival data from study transtar102-Cohort C 2023 ·Annals of Oncology ·Lin Shen, (unknown), Ningning Li, Weijian Guo, Tianshu Liu, Li Zhang, Xia Zhu, Chong Qi, Li Xu, Xiaoping Qian, Caroline Germa	3
5	Strong [O iii] λ5007 Compact Galaxies Identified from SDSS DR16 and Their Scaling Relations 2023 ·The Astronomical Journal ·(unknown), Hu Zou, Xu Kong, Yulong Gao, (unknown), Hong-Xin Zhang, Jiali Wang, Jie Song, (unknown), Jundan Nie, Suijian Xue, Weijian Guo, (unknown), Zhimin Zhou	3
6	1254P Updated report of a phase I study of TST001, a humanized anti-CLDN18.2 monoclonal antibody, in combination with capecitabine and oxaliplatin (CAPOX) as a first-line treatment of advanced G/GEJ cancer 2022 ·Annals of Oncology ·Lin Shen, (unknown), Na Li, Weijian Guo, (unknown), (unknown), Tianjun Liu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
7	Subcutaneous envafolimab monotherapy in patients with advanced defective mismatch repair/microsatellite instability high solid tumors 2021 ·Journal of Hematology & Oncology ·Jian Li, Yanhong Deng, Weijie Zhang, Aiping Zhou, Weijian Guo, Jianwei Yang, Ying Yuan, Liangjun Zhu, Shukui Qin, (unknown), Haolan Lu, (unknown), Ting Xu, David Liu, Lin Shen	92
8	Evaluation of 30 DNA damage response and 6 mismatch repair gene mutations as biomarkers for immunotherapy outcomes across multiple solid tumor types 2021 ·Cancer Biology and Medicine ·(unknown), Yue Yang, Jieyun Zhang, Weijian Guo	5
9	70MO Efficacy and safety of envafolimab (KN035) in advanced tumours with mismatch-repair deficiency 2020 ·Annals of Oncology ·(unknown), (unknown), Yanhong Deng, Weidong Zhang, Aiping Zhou, Weijian Guo, Jun Yang, Ying Yuan, Lirong Zhu, Shukui Qin, (unknown), (unknown), Hua Lu, (unknown), Ting Xu, (unknown)	4
10	Comparison of intravoxel incoherent motion imaging, diffusion kurtosis imaging, and conventional DWI in predicting the chemotherapeutic response of colorectal liver metastases 2020 ·European Journal of Radiology ·(unknown), Wenhua Li, Caixia Fu, Robert Grimm, Zhiyu Chen, Wen Zhang, Li‐Xin Qiu, Chenchen Wang, Xiaowei Zhang, Lei Yue, (unknown), Weijian Guo, Tong Tong	15
11	P1.01-28 Mutational Heterogeneity Between Primary Pulmonary Cancer Lesions and Matched Brain Metastases 2019 ·Journal of Thoracic Oncology ·(unknown), (unknown), (unknown), Dong Zhou, Xiaoyi Lin, Kai Yin, Hua Feng, Weijian Guo, (unknown), (unknown), (unknown), Lu Dai, Xue‐Ning Yang, (unknown), (unknown)	1
12	The prognostic value of age in non-metastatic gastric cancer after gastrectomy: a retrospective study in the U.S. and China 2018 ·Journal of Cancer ·Jieyun Zhang, Lu Gan, Midie Xu, Mingzhu Huang, Xiaowei Zhang, Yiwei Gong, Xi Wang, Guanzhen Yu, Weijian Guo	18
13	The Predictive and Prognostic Value of Early Metabolic Response Assessed by Positron Emission Tomography in Advanced Gastric Cancer Treated with Chemotherapy 2015 ·Clinical Cancer Research ·Chenchen Wang, Weijian Guo, Min Zhou, Xiaodong Zhu, Dongmei Ji, Wenhua Li, Xin Liu, Zhonghua Tao, Xiaowei Zhang, Yingjian Zhang, Jin Li	22
14	Gene mutations in gastric cancer: a review of recent next-generation sequencing studies 2015 ·Tumor Biology ·Yong Lin, Zhixiong Wu, Weijian Guo, (unknown)	51
15	Expression and significance of CD44 and p-AKT in pancreatic head cancer 2015 ·World Journal of Surgical Oncology ·Xiaoping Li, (unknown), (unknown), Weijian Guo	17
16	Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients 2014 ·BMC Cancer ·Wenhua Li, Jianming Xu, Lin Shen, Tianshu Liu, Weijian Guo, Wen Zhang, Zhiyu Chen, Xiaodong Zhu, Jin Li	6
17	18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer 2013 ·Nuclear Medicine Communications ·Min Zhou, Chenchen Wang, Silong Hu, Yongping Zhang, Zhifeng Yao, Jin Li, Weijian Guo, Yingjian Zhang	14
18	Intensity modulated radiation therapy and chemotherapy for locally advanced pancreatic cancer: Results of feasibility study 2003 ·World Journal of Gastroenterology ·Yongrui Bai, Guohua Wu, Weijian Guo, Xudong Wu, (unknown), Yin Chen, (unknown), (unknown)	23
19	Comparison between chemoembolization combined with radiotherapy and chemoembolization alone for large hepatocellular carcinoma 2003 ·World Journal of Gastroenterology ·Weijian Guo	70
20	[Reversal of nomegestrol acetate on multidrug resistance in drug-resistant human breast cancer cell line MCF7/ADR]. 2002 ·PubMed ·Jie Li, (unknown), (unknown), Weijian Guo, (unknown), (unknown), Peng Xia	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact